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 Introduction
Plasmid-mediated antibiotic resistance is commonly 
used as selection criterion for genetically engineered bac-
teria and fungi due to its effi  ciency and the availability of 
the respective drugs from commercial sources (1,2). For 
instance, many functional and genetic studies of yeast 
and other organisms require convenient plasmid tem-
plates for PCR-mediated gene disruptions, deletions (3), 
the recently developed bridge-induced translocation 
(BIT) system (4,5) and for many other purposes.
Combining two or three resistance genes simultane-
ously on the same DNA vector can facilitate selection and 
eliminate false positives (spontaneous acquisition of re-
sistance to three diff erent drugs is rather improbable, ex-
cluding resistance phenotypes caused by the elevated ef-
fl ux of drugs from the cell) (2,6). Moreover, a strict 
selection in combination with stable maintenance will be 
very advantageous when using shutt le plasmids as shut-
tle vectors for cloning purposes in yeast. For this reason, 
we decided to develop a plasmid that is highly selective 
for both expression purposes as well as for the prepara-
tion of functional analysis constructs, allowing a substan-
tial decrease in unwanted background resistance. This 
has been achieved by combining the coding sequences for 
antibiotic resistance to three widely available drugs: amp-
icillin, kanamycin (geneticin in yeast) and hygromycin B, 
in a specially engineered order. The result was the con-
struction of two plasmids (pMM and pMM-CEN) confer-
ring simultaneous resistance to these drugs, while lend-
ing themselves to be easily manipulated and utilized as 
vectors. As an experimental application of these new vec-
tors, the pMM plasmid was employed as PCR template in 
the BIT process (5). BIT utilizes homologous recombina-
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tion to physically bridge two loci of choice within the 
yeast genome, with a double-stranded DNA amplicon 
(cassett e) amplifi ed from a pMM template, in which a 
positively selectable marker is fl anked by short regions of 
homology (typically 65 bp) to the two loci of choice.
Materials and Methods
Bacteria and yeast strains
Escherichia coli XL1-Blue (catalog #200249; Stratagene, 
Santa Clara, CA, USA), Δ(mcrA)183 Δ(mcrCB-hsdSMR- 
-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac [F′ 
proAB lacIqZΔM15 Tn10 (Tetr)], E. coli Sure2 (catalog 
#200152; Stratagene), endA1 glnV44 thi-1 gyrA96 relA1 lac 
recB recJ sbcC umuC::Tn5 uvrC e14-Δ(mcrCB-hsdSMR- 
-mrr)171 F’[ proAB+ lacIq lacZΔM15 Tn10 Amy CmR] and E. 
coli DH5α (catalog #DA100; McLab, San Francisco, CA, 
USA), F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK– mK+), λ were 
used in this work. Strains XL1-Blue and Sure2 were used 
routinely for plasmid propagation, cloning and plasmid 
construction because of their colour screening and impro-
ved cloning effi  ciency. Strain DH5α is a more general type 
that was used as control of the effi  ciency of transforma-
tion. Luria Bertani (LB) broth for bacteria was prepared 
following standard protocols (7) and supplemented with 
100 μg/mL of ampicillin, 100 μg/mL of kanamycin and/or 
100 μg/mL of hygromycin B (Invitrogen, Carlsbad, CA, 
USA) as required. The Saccharomyces cerevisiae yeast strain 
SAN1 used in this work (MAT a/a ura3-52/ura3-52, lys2- 
-80/+, ade1/+, ade2-10/ade2, ade8/+, trp1-A1/trp1-289, his3-A200/+, 
leu2-Al/leu2, can1/+, arg4:FRTG-NLS-tetR-GFP/ARG4::FRTG- 
-DsRed) was previously developed in our laboratory (8). 
Yeast extract, peptone, dextrose (YPD; Difco, Sparks, MD, 
USA) supplemented with geneticin (G418) and/or hygro-
mycin B (fi nal concentration 200 and 300 μg/mL, respec-
tively) was used as a selective medium for yeast trans-
formants as described previously (9).
Plasmid construction
All described constructs were built on the pFA6a- 
-kanMX4 (accession number AJ002680; European Molecu-
lar Biology Laboratory, EMBL) plasmid platform (10). 
Firstly, the hygromycin B resistance gene (hphMX4) was 
amplifi ed from plasmid pAG32 using PCR (11). The PCR 
product was designed in such a way that it contained a 
BamHI restriction site at the 5’ end, the HygR gene, and the 
KpnI-BglII site at the 3’ end of the amplicon. Primers used 
for construction, verifi cation and testing are reported in 
Table 1.
All PCR reactions were carried out using Kapa HiFi 
polymerase (Kapa Biosystems, Woburn, MA, USA) follow-
ing the manufacturer’s instructions. The amplifi ed frag-
ments were purifi ed aft erwards using the Qiagen PCR 
product purifi cation kit (Qiagen GmbH, Hilden, Germa-
ny). Plasmid pFA6a-kanMX4 was linearized using Bam-
HI-BglII (New England Biolabs, Ipswich, MA, USA) and 
hphMX4, a hygromycin B resistance gene ending with ap-
propriate restriction sites, was ligated into the resulting 
gap using standard protocols (7). The DNA fragment was 
designed in such a way that it restored functional BamHI 
and BglII sites aft er ligation. The DNA construct was used 
to transform genetic recombination-defi cient Sure2 and 
XL1-Blue E. coli strains to ensure the lack of recombina-
tion events between neighbouring DNA translational 
elongation factor (TEF) elements, and the strains were 
plated on plates containing either or both ampicillin and 
hygromycin B (in the case of strain Sure2), or on plates 
with one or more of the ampicillin, kanamycin and hygro-
mycin B (for strain XL1-Blue). Aft er one day of growth, 
plasmids were isolated from one of the two strains using 
the Promega mini-prep kit (Promega, Madison, WI, USA) 
and used to transform the other E. coli strain. The DNA 
construct was verifi ed by PCR with primers specifi c for 
the kanamycin resistance, the hphMX4 and the combina-
tion of the two genes by restriction fragment length poly-
morphism (RFLP, using AatII, BglII, BamHI-BglII and MluI 
restriction enzymes) and fi nally validated by transform-
ing E. coli DH5α and selecting on LB agar plates con-
taining kanamycin, hygromycin B and ampicillin (7). The 
result ing plasmid was named pMM and it contained ge-
netic determinants conferring simultaneous resistance to 
ampicillin, kanamycin (geneticin for yeast) and hygromy-
cin B. Between the kanamycin and hphMX4 resistance 
genes there is a preferential cloning site that allows the 
use of both KpnI and BglII restriction enzymes. These sites 
were utilized when constructing pMM-CEN. Building 
upon the pMM cloning platform, a full length ARS1- 
-CEN4 DNA fragment with compatible ends derived by 
PCR from plasmid pYAC3 (12) was inserted between KpnI 
and BglII sites. The ARS1-CEN4 fragment was obtained 
using ARS-CEN4 primer set (Table 1) and ligated using a 
standard ligation protocol. Because only one pair of con-
venient restriction sites was used for cloning of the ARS- 
-CEN4 region, we decided to add a polylinker with the 
unique sites PacI, XmaI, KasI and insert it into the KpnI 
site. The resulting construct was verifi ed by PCR using 
primers specifi c for kanMX4, hphMX4, ARS-CEN4 and 
combinations of these genes. Additionally, restriction 
analysis was performed using the same enzymes as for 
pMM. Final validation was obtained by transformation of 
bacteria and yeast followed by selection on media con-
taining ampicillin, kanamycin, hygromycin B in diff erent 
combinations (for bacteria) and G418 and hygromycin B 
for yeast.
Transforming Saccharomyces cerevisiae
Saccharomyces cerevisiae San1 cells were transformed 
with the standard procedure described by Burke et al. (9) 
with the slight modifi cation of allowing cells to grow lon-
ger (1.5 h in YPD) under non-selective conditions before 
they were plated on selective medium to give them a bet-
ter chance to express all resistance genes. Bacterial trans-
formation was performed according to commonly known 
procedures (7).
Antibiotic resistance test
Bacterial colonies were picked and grown overnight 
in LB both supplemented with 100 μg/mL of ampicillin. 
The following day, 5 μL of every overnight culture were 
inoculated into the same medium. Cultures were grown 6 
h at 37 °C and then 5 mL of fresh selective medium con-
taining one or a combination of two or three antibiotics 
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were inoculated with 10 μL of these cultures and grown 
overnight. The following day, the absorbance was mea-
sured at 660 nm using a GeneQuant™ pro spectropho-
tometer (GE Healthcare, Litt le Chalfont, UK).
LB plates supplemented with increasing concentra-
tions of the antibiotics were used to assess the minimum 
inhibitory concentration (MIC) of the drugs. pMM-con-
taining E. coli DH5α strains were examined for suscepti-
bility to ampicillin, kanamycin and hygromycin B. The 
strains were transformed with appropriate plasmids for 
the experiments: pFA6a-kanMX4 to determine resistance 
to kanamycin, pUC18 to ampicillin and pAG32 to hygro-
mycin B. Wild type strain was used as a control. Final cell 
counts were adjusted to 103, 104, 105 and 106 CFU per mL 
of fresh culture per plate. Aft er 24 h of incubation at 37 °C, 
microbial growth was checked to determine the MIC val-
ue of the various antibiotics.
Plasmid copy number determination
Plasmid copy number was determined using an ap-
proach adapted from a previous report (13). First, an in-
ternal standard plasmid was constructed using the 
pGEM®-T Easy vector system (Promega). The internal 
standard plasmid contained both, one gene characteristic 
of the plasmid to be titrated (bla gene) and one specifi c for 
the bacterial chromosome (dxs). The relative primer sets 
are specifi ed in Table 1. A PCR mixture containing Kapa 
HiFi polymerase (Kapa Biosystems) and two sets of prim-
ers was amplifi ed twice at the limiting number of 20 and 
Table 1. Primers used for plasmid construction, copy number determination and the translocation cassett e production. Relevant re-
striction sites in primer sequences are writt en in italic and underlined
Plasmid construction and verifi cation
Primer sequence Description
F: CGGGATCCCGGACATGGAGGCCCAGAATACCCTCCT
R: GAAGATCTTCGGGGTACCCCCAGTATAGCGACCAGCATTC BamHI-HygR-BglII-KpnI set
F: GAAGATCTTCAAGCTGTCAAACATGAGAATCTG
R: GGGGTACCCCTTTATTCCCTTGTTGATTC ARS-CEN4 from pYAC3 set
F: ATGGGTAAAAAGCCTGAACTC
R: GAAAAACTCATCGAGCATCA Verifi cation of pMM and pMM-CEN
Plasmid copy number determination
F: CTACGATACGGGAGGGCTTA
R: ATAAATCTGGAGCCGGTGAG bla primer set
F: CGAGAAACTGGCGATCCTTA
R: CTTCATCAAGCGGTTTCACA dxs primer set










F: GGACATATTGTCGTTAGAACGCGGC+homology ChrXV (160605-160667)
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Kanamycin-specifi c probe synthesis
F: ATGGGTAAAAAGCCTGAACTC
R: AGATGTTGGCGACCTCGTAT
Hygromycin-specifi c probe synthesis
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21 cycles using a Thermo Hybaid Sprint PCR thermal cy-
cler (Ashford, Middlesex, UK). For the internal standard 
plasmid, the PCR reaction yielded two bands, which were 
subsequently subjected to densitometric analysis using a 
Pharmacia-LKB (Uppsala, Sweden) laser scanner densi-
tometer. The intensity of each band was measured three 
times, and the average value was used to calculate the in-
tensity ratio, which was normalized to 1. For each mea-
surement, two independent references were used (1 and 
2) and as an internal control, the copy number of refer-
ence 2 was determined using the values of reference 1 and 
vice versa. When PCR amplifi cation was carried out on ge-
nomic DNA of cells containing a plasmid, the reaction 
also yielded two bands: a plasmid-borne bla fragment and 
a chromosomal dxs. Calculating their ratio and compar-
ing it to the normalized value of the internal standard, the 
relative plasmid copy number per cell was calculated. For 
each sample, references 1 and 2 were used, and the aver-
age value was accepted. In total, these measurements 
were repeated 12 times, every time using two internal 
standards and those from samples 1 to 3.
Bacterial transformation effi  ciency
Both of the constructed plasmids, pMM and pMM- 
-CEN, were used to transform E. coli DH5α strain and the 
transformants were selected on ampicillin, kanamycin, 
hygromycin B, ampicillin-kanamycin, ampicillin-hygro-
mycin B, kanamycin-hygromycin B and ampicillin-kana-
mycin-hygromycin B plates (100 μg/mL of each antibi-
otic). Aft er incubation, number of CFU was determined 
using a colony counter (Gallenkamp Co, Ltd, London, 
UK). The transformation effi  ciency was calculated as the 
number of transformants per μg of DNA.
Bridge-induced translocations
Bridge-induced translocation (BIT) is a system that 
allows to produce chromosomal translocations between 
any two genomic loci of choice on diff erent chromosomes 
by means of a PCR-derived DNA bridge called transloca-
tion cassett e. This is a fragment of DNA where a resist-
ance gene is fl anked by two short regions (usually around 
64 bp), each homologous to its chromosomal target. pMM 
and pMM-CEN off er the possibility, as DNA templates, to 
amplify cassett es with kanamycin, hygromycin and kan-
amycin-hygromycin on the same amplicon. In addition, 
pMM-CEN allows the amplifi cation of a DNA cassett e 
harbouring the CEN4 and an ARS between the kanamy-
cin and hphMX4 resistance genes, thus allowing to test its 
capacity of bridging two chromosomal portions that do 
not carry any centromere, a would-be novelty for the BIT 
system. The pMM plasmid was used as a template for 
amplifi cation of the BIT translocation cassett e aimed to 
bridge ADH1 locus localized on chromosome XV and SUC2 
locus on chromosome IX in S. cerevisiae as described pre-
viously (5). Translocation cassett es were produced using 
Kapa HiFi polymerase (Kapa Biosystems), which con-
tained the two genes conferring resistance to kanamycin 
and hygromycin B and were used to transform S. cerevi-
siae San1 strain. Transformants were initially tested on 
YPD plates containing G418 and hygromycin B. Recombi-
nation of the DNA cassett e ends into each involved chro-
mosome was tested by colony PCR using the mixture of 
three primers (Table 1), two localized on the genomic se-
quences and one localized on the translocation cassett e. In 
the case of chromosome translocation, a product of chro-
mosomal primer and cassett e primer was visible (two 
bands). Detected translocants were examined by CHEF 
(contour-clamped homogeneous electric fi eld) analysis as 
described by Tosato et al. (5) and subsequently by South-
ern blott ing with the digoxigenin-labelled probes (DIG 
probe synthesis kit, Roche, Basel, Switzerland) for kan-
amycin and hphMX4 resistance genes to verify the pres-
ence of an aberrant chromosome. Primers used for probe 
synthesis are shown in Table 1.
Results and Discussion
Construct structure
Here we report the genetic organization and restric-
tion map of two novel, multidrug resistant marker plas-
mids: pMM (5581 bp) (Fig. 1) and pMM-CEN (7556 bp) 
(Fig. 2).
These plasmid constructs contain four important 
gene tic elements placed on the same DNA molecule: a 
dominant resistance gene for ampicillin (bla), kanamycin 
(kanMX4 in bacteria) and geneticin (G418 in yeast), hygro-
mycin (hphMX4) (11), and an ARS-CEN4 DNA module 
(only for pMM-CEN) providing stable maintenance in the 
yeast cells. The kanMX4 is a DNA segment containing the 
open reading frame of aminoglycoside phosphotrans-
ferase from E. coli transposon Tn903 and the TEF1 (trans-
lation elongation factor) promoter and terminator derived 
from the fi lamentous fungus Ashbya gossypii, providing 
transcriptional and translational control (10,14). Expres-
sion of kanMX4 renders bacteria resistant to kanamycin 
and yeast cells resistant to geneticin (G418) (15,16). The 
presence of the hphMX4 gene confers resistance to the an-
tibiotic hygromycin B (11) and the coding region of this 
Fig. 1. pMM vector map with unique restriction sites. This con-
struct contains functional cassett es conferring resistance to hy-
gromycin (HygR), kanamycin (KanR), and ampicillin (AmpR). 
Both, kanamycin and hygromycin are under control of the tran-
slation elongation factor (TEF) promoter and terminator. Num-
bers in brachets represent the position of the restriction sites
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gene is also under the transcriptional and translational 
control of the TEF1 promoter and terminator. The correct 
presence of these elements was confi rmed by colony 
PCRs, as explained in Materials and Methods. For con-
struction of pMM-CEN, the full-length ARS-CEN4 region 
from the pYAC3 plasmid was inserted between the KpnI 
and BglII sites. The lack of convenient restriction sites be-
tween the markers on pMM-CEN prompted us to add a 
polylinker fragment in the KpnI site carrying PacI, XmaI 
and KasI sites. PacI leaves 3’ overhang, whereas Xmal and 
KasI leave 5’ overhang, successfully preventing self-liga-
tion. Additionally, they work in the same buff ers and do 
not exhibit star activity, which makes working with them 
very simple. These cloning sites can be utilized in several 
diff erent ways, allowing construction of two-marker cas-
sett es separated by any DNA sequence or two-marker 
cassett e with a centromeric sequence. Suggested primers 
for cassett e amplifi cation are shown in Table 1.
These primers were practically tested on the pMM- 
-CEN template and their PCR products showed the cor-
rect size (not shown).
Antibiotic resistance tests
Resistance tests indicate that both yeast and bacterial 
cells were rendered resistant to kanamycin and hygromy-
cin B by the introduction of the pMM plasmid. These two 
drugs belong to the same group of aminoglycosidic anti-
biotics and have a similar mode of action (17–21), which 
helps to reduce the incidence of spontaneous resistance 
and lowers the percentage of false positives. Additionally, 
the plasmid confers resistance to ampicillin thanks to the 
presence of the b-lactamase gene, thus providing addi-
tional means for selection in bacteria (22,23). When bacte-
rial cells were transformed with pMM, they exhibited re-
sistance to each of the drugs separately, as well as to all 
combinations of these agents (ampicillin-kanamycin, am-
picillin-hygromycin B, kanamycin-hygromycin B and 
ampicillin-kanamycin-hygromycin B), rendering this sys-
tem quite fl exible for the selection of multiple resistances. 
The same was observed in the case of yeast transforma-
tion, where the presence of pMM renders cells able to 
grow on geneticin- and/or hygromycin B-containing plates 
(200 μg/mL of G418 and 300 μg/mL of hygromycin B, re-
spectively). Transformation with the second plasmid con-
struct, pMM-CEN, confi rmed these results. However, 
pMM-containing yeast colonies were, as expected, small-
er than pMM-CEN, due to the lack of stable maintenance 
and transmission of the plasmid within the population. 
We tested the range of plasmid-mediated resistance on 
each of the drugs separately and in combinations with 
each other and determined transformation effi  ciency.
The minimum inhibitory concentration (MIC) was 
tested with E. coli DH5α strains transformed with diff er-
ent plasmids by their ability to produce visible growth on 
a series of agar plates that contain increasing concentra-
tions of three antibiotics. The concentration of ampicillin 
on LB agar plates was between 50 and 100 μg/mL, of ka-
namycin was between 100 and 5000 μg/mL, and of hygro-
mycin B between 100 and 5000 μg/mL.
As shown in Fig. 3, the range of plasmid-mediated 
resistance to each of the drugs was tested separately and 
compared with parental plasmid resistance (see Materials 
and Methods). In the case of ampicillin, all tested bacteri-
al clones were surprisingly resistant up to 10 000 μg/mL. 
When tested on kanamycin, cells containing pFA6a-kan-
MX4 and pMM exhibited resistance up to 1000 μg/mL 
and no fl uctuations of the values compared to the paren-
tal plasmid were observed. A diff erent situation was no-
ticed in the hygromycin B resistance test, in which pMM- 
-containing cells grew in a medium with 2000 μg/mL of 
the drug, while the parental plasmid pAG32 carrying the 
resistance gene phpMX4 exhibited only slight growth in 
1000 μg/mL of hygromycin B medium. One possible ex-
planation of this phenomenon could be that the phpMX4 
promoter on pMM plasmid is subject to a greater rate of 
activation than when located on pAG32.
Bacterial transformation effi  ciency and selection of 
diff erent markers
Since bacteria harbouring one of our newly con-
structed plasmids should exhibit resistance to the three 
markers separately, as well as in mixed confi gurations, we 
transformed bacterial cells with pMM and pMM-CEN 
and selected on ampicillin, kanamycin, hygromycin B 
and the combination of ampicillin-kanamycin, ampicillin-
-hygromycin B, kanamycin-hygromycin B and ampicillin-
-kanamycin-hygromycin B plates. Each transformation 
was repeated 3 times using the same aliquot of pMM and 
pMM-CEN miniprep. To visualize the infl uence of single, 
double and triple selection on the number of transfor-
mants, transformation effi  ciencies were calculated of both 
plasmids when growing on media containing diff erent 
combinations of the drugs. The results (Table 2) showed 
that the highest transformation effi  ciency of both plas-
mids was observed when single selection was applied. 
These values dropped as expected when two drugs were 
Fig. 2. pMM-CEN vector map with unique restriction sites. This 
vector can be used as a shutt le vector due to the presence of 
CEN4 and ARS elements providing stable maintenance in the 
buddying yeast. Analogously to the previous vector, this con-
struct confers resistance to kanamycin (KanR) and hygromycin 
(HygR) thanks to the cassett es present within its structure. 
Moreover, for selection in the bacterial hosts, ampicillin might 
be used due to the presence of the AmpR gene. TEF=translation 
elongation factor. Numbers in brachets represent the position 
of the restriction sites
262 R. ARNAK et al.: Multiple Antibiotic Resistance Plasmids, Food Technol. Biotechnol. 54 (3) 257–265 (2016)
used, with the most toxic being ampicillin-kanamycin. 
When three markers were combined, the transformation 
effi  ciency was reduced fi ve- (pMM) and tenfold (pMM- 
-CEN). Triple selection allowed only triple-resistant cells 
to divide and potentially eliminate all background of fal-
se transformants.
On the other hand, since both KanR and HygR resis-
tance genes share the same TEF1 promoter/terminator el-
ements, recombination between their copies cannot be 
excluded, although a rec¯ strain was used. In this case, re-
combination between two direct DNA repeats represen-
ted by the TEF1 promoter sequences on plasmid pMM 
would lead to the excision of the hphMX4 resistance gene, 
while recombination between the two TEF1 terminators 
would lead to excision and loss of the KanR marker. There-
fore, what could have been interpreted as background, i.e. 
the loss of a resistance phenotype, could very well be due 
to the loss of a portion of the plasmid carrying that resi-
stance gene, which underwent recombination, rather than 
a classical background due to spontaneous mutation.
Plasmid copy number
The observed high levels of antibiotic resistance 
could suggest that plasmids exist in high copy numbers 
in bacterial cells (in yeast cells, pMM-CEN number is lim-
ited to one or two due to the presence of centromeric se-
quences), while the control plasmids, pAG32 and pFA6a- 
-kanMX4 showed approx. 15-20 copies per cell (data not 
shown) and pUC18 is reported to reach a very high copy 
number of more than 500 (24,25). To our surprise, aft er 
combining data from 12 independent experiments, we ob-
served that copy number is rather moderate and oscillates 
around 10 copies per cell (10.77±1.57). Moreover, these 
plasmids can be stably maintained for almost twenty gen-
erations in bacteria.
Table 2. Transformation effi  ciency values of plasmids pMM and pMM-CEN determined for diff erent combinations of antibiotics
Amp Kan Hyg Amp-Kan Kan-Hyg Amp-Hyg Amp--Kan-Hyg
pMM
Average transformation effi  ciency 1.81·104 1.29·104 1.66·104 0.95·104 1.28·104 1.31·104 0.44·104
SEM 0.12·104 0.09·104 0.11·104 0.90·104 0.10·104 0.07·104 0.06·104
pMM-
-CEN
Average transformation effi  ciency 0.82·104 0.65·104 0.70·104 0.11·104 0.16·104 0.42·104 0.08·104
SEM 1.81·104 1.29·104 1.66·104 0.02·104 0.02·104 0.01·104 0.01·104
Amp=ampicillin, Kan=kanamycin, Hyg=hygromycin, SEM=standard error of the mean (N=3)
Fig. 3. Determination of minimum inibitory concentration (MIC) values with pMM-containing cells on each of the diff erent concen-
trations of drugs. E. coli DH5μ strains were used for the experiments with the appropriate plasmids: pFA6a-kanMX4 for kanamycin, 
pUC18 for ampicillin and pAG32 for hygromycin B resistance. The spots represent growth of diff erent dilutions of a cell culture 
starting with approx. 103 cells/mL from left  to right. Amp=ampicillin, Hyg=hygromycin, Kan=kanamycin, wt=wild type strains
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The pMM plasmid as a useful template for the 
production of BIT DNA cassett es
As an experimental application of these new vectors, 
the pMM plasmid was employed for the amplifi cation of 
DNA cassett es used for bridge-induced chromosome 
translocation (BIT) between the two yeast loci ADH1 on 
chromosome XV and SUC2 on chromosome IX (Fig. 4). 
We successfully produced a KanR-HygR DNA cassett e by 
PCR on the pMM template, utilizing the primers descri-
bed in Table 1. This DNA cassett e was then used to trans-
form yeast to induce translocations between chromo-
somes IX and XV.
Aft er colony PCR screen, we were able to fi nd trans-
locants resistant to kanamycin and hygromycin B simul-
taneously. The stability of pMM-derived cassett e was con-
fi rmed by a CHEF gel when compared to the wild type 
San1 strain (not shown). Moreover, Southern hybridiza-
tion revealed strong signal when kanamycin- or hygromy-
cin B-specifi c probe was used and this is a strong evidence 
that translocation cassett e gets integrated into selected 
loci and is not lost during cell division. Verifi cation exper-
iments are summarized in Fig. 5. This demonstrated a 
successful application of this new vector and the relative 
in vivo stability of the two markers in a recombination 
profi cient yeast strain.
The added value of this vector with respect to a sin-
gle-marker one is that, at the onset of selection aft er trans-
formation, one can immediately apply a single (resistance 
to kanamycin or hygromycin B) or double (resistance to 
both) selection, thereby imposing a much fl exible and re-
strictive selective pressure on the cells that have uptaken 
the transforming DNA plasmid. According to our pre-
vious experience with BIT, this vector signifi cantly impro-
ved the selection effi  ciency, as it was possible to select on 
much higher doses of one antibiotic, or on two antibiotics, 
thereby reducing the false-positive background by an 
estimated 35 or 55 %, respectively. When we performed 
BIT with a DNA cassett e amplifi ed on the pMM template, 
we measured the rate of excision between TEF regions by 
counting cells that lost resistance to one or the other drug, 
due to direct repeat recombination. The ratio was rather 
low, as out of 800 yeast colonies originally resistant to 
both drugs, 62 (7.75 %) exhibited excision of the KanR 
marker, and 30 (3.75 %) of the HygR.
Recombination between TEF elements on pMM-CEN 
should also lead to the exclusion of the centromere CEN 
and ARS elements, thus this plasmid would be quickly 
Fig. 4. At the top of the fi gure, the PCR amplifi cation of the cas-
sett e carrying the KanR-HygR genes using the pMM template is 
shown. The primers used, named F (forward) and R (reverse; 
sequences in Table 1), are drawn in the fi gure as thick black ar-
rows. At the bott om, the scheme of the translocation between 
chromosomes XV and IX is represented. The primers used to 
check the correct integration and their relative position are in-
dicated by thin arrows with sequence numbers. The two break 
lines on chromosome XIV indicate that the drawing of the chro-
mosomes is not proportional
Fig. 5. a) Colony PCR verifi cation of translocants obtained with 
KanR-HygR cassett e: lane 1A: ADH1 band obtained on San1 strain. 
Lane 1B: PCR product obtained from San1 strain carrying the 
translocated chromosome. The upper band reveals integration 
of the cassett e into chromosome XV, while the lower band is the 
ADH1 wild type (wt) band. Analogously, lanes 2A and 2B con-
tain colony PCR products on the wt and translocant strain for 
the second translocation point (SUC2 on chromosome IX); b) 
CHEF gel electrophoresis of translocation involving chromo-
somes XV and IX. Lane 1: wt San1 strain, lane 2: San1 translo-
cant; c) and d) Southern hybridization with DIG probe specifi c 
for kanamycin and hygromycin respectively, providing direct 
evidence of translocation cassett e integration into the buddying 
yeast genome
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lost in the population. Furthermore, the inclusion of the 
ARS-CEN DNA, encoding a DNA sequence for the yeast 
origin of replication and the centromere, would allow the 
recovery of translocations connecting two portions of 
chromosomes devoided of them.
S. cerevisiae is a very important organism employed 
during various genetic analyses in which gene disruption, 
deletion, tagging, or cloning are the main part of the 
whole experimental assay. Gene cloning in yeast requires 
convenient shutt le plasmids (integrative, centromeric or 
episomal) like the commonly used vectors of the pRS se-
ries (26) and their further modifi cations (26–28). In addi-
tion, genome manipulations such as gene deletions or re-
placements are usually based on drug resistance markers 
used for gene disruption or tagging (29,30) and require 
convenient PCR templates for amplifi cation of deletion 
cassett es. The majority of the vectors present on the mar-
ket off er the possibility of selection by the means of auxo-
trophic markers. However, this is not always convenient, 
as frequently the strain is marker-incompatible (which re-
quires additional manipulation of the genome and gener-
ation of designer strains (31,32)). Moreover, in particular 
approaches, the experimental set up might require growth 
in rich medium, which renders auxotrophic selection im-
possible. Transformation-associated background can be 
another condition rendering some experiments very diffi  -
cult. A similar system, where the URA3 marker was re-
placed by the kanMX4 module has been constructed, but 
until now no double antibiotic selection marker has been 
available (33). In this work, we observed simultaneous re-
sistance up to two (in the case of yeast) and three (in bac-
teria) antibiotic agents. Another interesting and impor-
tant result is that reported in Fig. 3, where the growth 
tests demonstrated a superior resistance of bacteria to a 
particular antibiotic when all three, ampicillin, kanamy-
cin and hygromycin B resistance genes were present and 
expressed on the same plasmid carrier. Although the na-
ture of the metabolic interaction leading to this phenome-
non is not clear, its role in the understanding of sponta-
neous acquisition of multiple antibiotic resistance must 
be considered. This result warrants an analogous investi-
gation in yeast to verify the possible extension of the phe-
nomenon to eukaryotic model cell system as well.
Conclusions
Our two newly produced plasmid constructs, pMM 
and pMM-CEN, carry features making them very handy 
and valuable tools for all modern molecular biology tasks, 
especially in functional analyses, recombinant DNA work 
and cloning experiments. The newly constructed pMM 
and pMM-CEN can be used for these approaches and 
possess the advantage of permitt ing the amplifi cation of 
one, two or three antibiotics on the same DNA cassett e, 
over commonly used vectors. Moreover, pMM-CEN al-
lows the inclusion of a centromere DNA sequence able to 
stabilize the newly formed transforming chromosome la-
cking its own centromere DNA sequence. These plasmids 
can be used completely independently from the auxotro-
phic markers in the host strain, allowing their utilization 
in natural yeast isolates where strains were heavily ma-
nipulated and no auxotrophic selection marker is avail-
able.
Our initial goal was to build a multi-marker plasmid 
system, believing that this could be used readily as it is, 
while further applications have proven its additional val-
ue as a convenient platform for further genomic modifi ca-
tions. The experimental results indicated that clones car-
rying these constructs could be subjected to very stringent 
selective conditions like the triple selection that can be 
successfully used facilitating the limitation of an unwant-
ed background. In order to validate the pMM plasmid 
ability to be used as a PCR template for genome manipu-
lation, we used it as a template for amplifying a chromo-
some translocation DNA cassett e used subsequently in 
the BIT procedure. As expected, the cassett e successfully 
induced translocation between the ADH1 and SUC2 loci. 
The resulting clones carried the correct translocated chro-
mosome and exhibited resistance to kanamycin and hy-
gromycin B drugs separately and in combination. The use 
of double selection lowered the background, probably by 
allowing only the most fi t clones to survive. Another issue 
when working with yeast shutt le plasmids is the lack of 
convenient restriction sites for cloning. To expand more the 
versatility of pMM-CEN, a polylinker containing unique 
restriction sites was added. In addition to the ability of this 
plasmid to be stably maintained and transmitt ed through 
generations, the presence of these cloning sites will great-
ly facilitate the work with this vector.
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